ArticleMicrobiology spectrum2026

Impact of nonalcoholic fatty liver disease on the response to pegylated interferon-α therapy in patients with chronic hepatitis B.

Huiqing Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.